← Open Payments lookup

ABIGAIL BURKE: Open Payments

NPI 1487387866 · SHERIDAN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$409 in 22 payments from 11 companies in 2025. Trend: 2023 $680 · 2024 $977 · 2025 $409

Food & beverage: $409
CompanyPaymentsAmount
Novo Nordisk Inc5$96
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
ABBVIE INC.3$66
AstraZeneca Pharmaceuticals LP3$45
GlaxoSmithKline, LLC.2$29
Bayer Healthcare Pharmaceuticals Inc.1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21
Amgen Inc.1$17
PFIZER INC.1$15
Lilly USA, LLC1$14

Products named: CAPLYTA, VRAYLAR, Ozempic, AIRSUPRA, SHINGRIX, Kerendia, XIFAXAN, UBRELVY.

Industry payments across IN — which companies pay providers there.